{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:13:59Z","timestamp":1778800439979,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LZ24H180002"],"award-info":[{"award-number":["LZ24H180002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302135"],"award-info":[{"award-number":["82302135"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302138"],"award-info":[{"award-number":["82302138"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302132"],"award-info":[{"award-number":["82302132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00415-024-12811-5","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T12:22:07Z","timestamp":1734006127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["LRRK2 mutation contributes to decreased free water in the nucleus basalis of Meynert in manifest and premanifest Parkinson\u2019s disease"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5268-9570","authenticated-orcid":false,"given":"Chao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"key":"12811_CR1","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE (2017) Parkinson disease. Nat Rev Dis Primers 3:17013","journal-title":"Nat Rev Dis Primers"},{"key":"12811_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1474-4422(16)30345-3","volume":"16","author":"P Calabresi","year":"2017","unstructured":"Calabresi P, Tambasco N (2017) Movement disorders in 2016: from genes to phenotypes. Lancet Neurol 16:9\u201310","journal-title":"Lancet Neurol"},{"key":"12811_CR3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy DG, Falchi M, O\u2019Sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S, Ferreira JJ, Tolosa E, Kay DM, Klein C, Williams DR, Marras C, Lang AE, Wszolek ZK, Berciano J, Schapira AH, Lynch T, Bhatia KP, Gasser T, Lees AJ, Wood NW (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study. Lancet Neurol 7:583\u2013590","journal-title":"Lancet Neurol"},{"key":"12811_CR4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMc055509","volume":"354","author":"LJ Ozelius","year":"2006","unstructured":"Ozelius LJ, Senthil G, Saunders-Pullman R, Ohmann E, Deligtisch A, Tagliati M, Hunt AL, Klein C, Henick B, Hailpern SM, Lipton RB, Soto-Valencia J, Risch N, Bressman SB (2006) LRRK2 G2019S as a cause of Parkinson\u2019s disease in Ashkenazi Jews. N Engl J Med 354:424\u2013425","journal-title":"N Engl J Med"},{"key":"12811_CR5","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/mds.25647","volume":"28","author":"RN Alcalay","year":"2013","unstructured":"Alcalay RN, Mirelman A, Saunders-Pullman R, Tang MX, Mejia Santana H, Raymond D, Roos E, Orbe-Reilly M, Gurevich T, Bar Shira A, Gana Weisz M, Yasinovsky K, Zalis M, Thaler A, Deik A, Barrett MJ, Cabassa J, Groves M, Hunt AL, Lubarr N, San Luciano M, Miravite J, Palmese C, Sachdev R, Sarva H, Severt L, Shanker V, Swan MC, Soto-Valencia J, Johannes B, Ortega R, Fahn S, Cote L, Waters C, Mazzoni P, Ford B, Louis E, Levy O, Rosado L, Ruiz D, Dorovski T, Pauciulo M, Nichols W, Orr-Urtreger A, Ozelius L, Clark L, Giladi N, Bressman S, Marder KS (2013) Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations. Mov Disord 28:1966\u20131971","journal-title":"Mov Disord"},{"key":"12811_CR6","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/mds.26161","volume":"30","author":"S Srivatsal","year":"2015","unstructured":"Srivatsal S, Cholerton B, Leverenz JB, Wszolek ZK, Uitti RJ, Dickson DW, Weintraub D, Trojanowski JQ, Van Deerlin VM, Quinn JF, Chung KA, Peterson AL, Factor SA, Wood-Siverio C, Goldman JG, Stebbins GT, Bernard B, Ritz B, Rausch R, Espay AJ, Revilla FJ, Devoto J, Rosenthal LS, Dawson TM, Albert MS, Mata IF, Hu SC, Montine KS, Johnson C, Montine TJ, Edwards KL, Zhang J, Zabetian CP (2015) Cognitive profile of LRRK2-related Parkinson\u2019s disease. Mov Disord 30:728\u2013733","journal-title":"Mov Disord"},{"key":"12811_CR7","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/mds.26614","volume":"31","author":"C Marras","year":"2016","unstructured":"Marras C, Alcalay RN, Caspell-Garcia C, Coffey C, Chan P, Duda JE, Facheris MF, Fern\u00e1ndez-Santiago R, Ru\u00edz-Mart\u00ednez J, Mestre T, Saunders-Pullman R, Pont-Sunyer C, Tolosa E, Waro B (2016) Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson\u2019s disease. Mov Disord 31:1192\u20131202","journal-title":"Mov Disord"},{"key":"12811_CR8","doi-asserted-by":"crossref","first-page":"e814","DOI":"10.1212\/WNL.0000000000200737","volume":"99","author":"R Saunders-Pullman","year":"2022","unstructured":"Saunders-Pullman R, Ortega RA, Wang C, Raymond D, Elango S, Leaver K, Urval N, Katsnelson V, Gerber R, Swan M, Shanker V, Alcalay RN, Mirelman A, Brumm MC, Mejia-Santana H, Coffey CS, Marek K, Ozelius LJ, Giladi N, Marder KS, Bressman SB (2022) Association of olfactory performance with motor decline and age at onset in people with Parkinson disease and the LRRK2 G2019S variant. Neurology 99:e814\u2013e823","journal-title":"Neurology"},{"key":"12811_CR9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","volume":"47","author":"K Wakabayashi","year":"2013","unstructured":"Wakabayashi K, Tanji K, Odagiri S, Miki Y, Mori F, Takahashi H (2013) The Lewy body in Parkinson\u2019s disease and related neurodegenerative disorders. Mol Neurobiol 47:495\u2013508","journal-title":"Mol Neurobiol"},{"key":"12811_CR10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","volume":"72","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW, Ross OA, Van Deerlin VM, Trojanowski JQ, Hurtig HI, Alcalay RN, Marder KS, Clark LN, Gaig C, Tolosa E, Ruiz-Mart\u00ednez J, Marti-Masso JF, Ferrer I, L\u00f3pez de Munain A, Goldman SM, Sch\u00fcle B, Langston JW, Aasly JO, Giordana MT, Bonifati V, Puschmann A, Canesi M, Pezzoli G, Maues De Paula A, Hasegawa K, Duyckaerts C, Brice A, Stoessl AJ, Marras C (2015) Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol 72:100\u2013105","journal-title":"JAMA Neurol"},{"key":"12811_CR11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/mds.24962","volume":"27","author":"M Poulopoulos","year":"2012","unstructured":"Poulopoulos M, Levy OA, Alcalay RN (2012) The neuropathology of genetic Parkinson\u2019s disease. Mov Disord 27:831\u2013842","journal-title":"Mov Disord"},{"key":"12811_CR12","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/mds.26529","volume":"31","author":"N Dzamko","year":"2016","unstructured":"Dzamko N, Rowe DB, Halliday GM (2016) Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers. Mov Disord 31:889\u2013897","journal-title":"Mov Disord"},{"key":"12811_CR13","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain 136:2419\u20132431","journal-title":"Brain"},{"key":"12811_CR14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1474-4422(19)30319-9","volume":"19","author":"T Simuni","year":"2020","unstructured":"Simuni T, Uribe L, Cho HR, Caspell-Garcia C, Coffey CS, Siderowf A, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Tosun D, Poston K, Weintraub D, Mollenhauer B, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten SJ, Bressman S, Marek K (2020) Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson\u2019s Progression Markers Initiative (PPMI): a cross-sectional study. Lancet Neurol 19:71\u201380","journal-title":"Lancet Neurol"},{"key":"12811_CR15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jnnp.48.5.413","volume":"48","author":"EK Perry","year":"1985","unstructured":"Perry EK, Curtis M, Dick DJ, Candy JM, Atack JR, Bloxham CA, Blessed G, Fairbairn A, Tomlinson BE, Perry RH (1985) Cholinergic correlates of cognitive impairment in Parkinson\u2019s disease: comparisons with Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 48:413\u2013421","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12811_CR16","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1073\/pnas.84.16.5976","volume":"84","author":"EC Hirsch","year":"1987","unstructured":"Hirsch EC, Graybiel AM, Duyckaerts C, Javoy-Agid F (1987) Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci U S A 84:5976\u20135980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12811_CR17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1474-4422(21)00377-X","volume":"21","author":"NI Bohnen","year":"2022","unstructured":"Bohnen NI, Yarnall AJ, Weil RS, Moro E, Moehle MS, Borghammer P, Bedard MA, Albin RL (2022) Cholinergic system changes in Parkinson\u2019s disease: emerging therapeutic approaches. Lancet Neurol 21:381\u2013392","journal-title":"Lancet Neurol"},{"key":"12811_CR18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.22691","volume":"71","author":"V Kotagal","year":"2012","unstructured":"Kotagal V, Albin RL, M\u00fcller ML, Koeppe RA, Chervin RD, Frey KA, Bohnen NI (2012) Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann Neurol 71:560\u2013568","journal-title":"Ann Neurol"},{"key":"12811_CR19","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/brain\/awq079","volume":"133","author":"NI Bohnen","year":"2010","unstructured":"Bohnen NI, M\u00fcller ML, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, Frey KA (2010) Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson\u2019s disease. Brain 133:1747\u20131754","journal-title":"Brain"},{"key":"12811_CR20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jamaneurol.2014.2757","volume":"72","author":"NI Bohnen","year":"2015","unstructured":"Bohnen NI, Albin RL, M\u00fcller ML, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Frey KA (2015) Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects. JAMA Neurol 72:194\u2013200","journal-title":"JAMA Neurol"},{"key":"12811_CR21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1474-4422(15)00389-0","volume":"15","author":"EJ Henderson","year":"2016","unstructured":"Henderson EJ, Lord SR, Brodie MA, Gaunt DM, Lawrence AD, Close JC, Whone AL, Ben-Shlomo Y (2016) Rivastigmine for gait stability in patients with Parkinson\u2019s disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol 15:249\u2013258","journal-title":"Lancet Neurol"},{"key":"12811_CR22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-019-05354-5","volume":"237","author":"A Kucinski","year":"2020","unstructured":"Kucinski A, Phillips KB, Koshy Cherian A, Sarter M (2020) Rescuing the attentional performance of rats with cholinergic losses by the M1 positive allosteric modulator TAK-071. Psychopharmacology 237:137\u2013153","journal-title":"Psychopharmacology"},{"key":"12811_CR23","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/mrm.22055","volume":"62","author":"O Pasternak","year":"2009","unstructured":"Pasternak O, Sochen N, Gur Y, Intrator N, Assaf Y (2009) Free water elimination and mapping from diffusion MRI. Magn Reson Med 62:717\u2013730","journal-title":"Magn Reson Med"},{"key":"12811_CR24","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/mds.27100","volume":"32","author":"E Ofori","year":"2017","unstructured":"Ofori E, Krismer F, Burciu RG, Pasternak O, McCracken JL, Lewis MM, Du G, McFarland NR, Okun MS, Poewe W, Mueller C, Gizewski ER, Schocke M, Kremser C, Li H, Huang X, Seppi K, Vaillancourt DE (2017) Free water improves detection of changes in the substantia nigra in parkinsonism: a multisite study. Mov Disord 32:1457\u20131464","journal-title":"Mov Disord"},{"key":"12811_CR25","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/mds.29366","volume":"38","author":"G Zhou","year":"2023","unstructured":"Zhou G, Ren J, Rong D, Zhou H, Ning H, Wang H, Pan C, Wang Y, Zhang R, Guo Z, Huang P, Liu W (2023) Monitoring substantia nigra degeneration using free water imaging across prodromal and clinical Parkinson\u2019s disease. Mov Disord 38:774\u2013782","journal-title":"Mov Disord"},{"key":"12811_CR26","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/acn3.644","volume":"5","author":"K Marek","year":"2018","unstructured":"Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Simuni T, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun-Turgut D, Poston K, Arnedo V, Frasier M, Sherer T (2018) The Parkinson\u2019s progression markers initiative (PPMI)\u2014establishing a PD biomarker cohort. Ann Clin Transl Neurol 5:1460\u20131477","journal-title":"Ann Clin Transl Neurol"},{"key":"12811_CR27","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/mgg3.151","volume":"3","author":"T Foroud","year":"2015","unstructured":"Foroud T, Smith D, Jackson J, Verbrugge J, Halter C, Wetherill L, Sims K, Xin W, Arnedo V, Lasch S, Marek K (2015) Novel recruitment strategy to enrich for LRRK2 mutation carriers. Mol Genet Genomic Med 3:404\u2013412","journal-title":"Mol Genet Genomic Med"},{"key":"12811_CR28","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1126\/science.abb4588","volume":"369","author":"K Amunts","year":"2020","unstructured":"Amunts K, Mohlberg H, Bludau S, Zilles K (2020) Julich-Brain: a 3D probabilistic atlas of the human brain\u2019s cytoarchitecture. Science 369:988\u2013992","journal-title":"Science"},{"key":"12811_CR29","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1007\/s00429-016-1356-0","volume":"222","author":"A Alho","year":"2017","unstructured":"Alho A, Hamani C, Alho EJL, da Silva RE, Santos GAB, Neves RC, Carreira LL, Ara\u00fajo CMM, Magalh\u00e3es G, Coelho DB, Alegro MC, Martin MGM, Grinberg LT, Pasqualucci CA, Heinsen H, Fonoff ET, Amaro E Jr (2017) Magnetic resonance diffusion tensor imaging for the pedunculopontine nucleus: proof of concept and histological correlation. Brain Struct Funct 222:2547\u20132558","journal-title":"Brain Struct Funct"},{"key":"12811_CR30","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.118703","volume":"245","author":"M Eshaghzadeh Torbati","year":"2021","unstructured":"Eshaghzadeh Torbati M, Minhas DS, Ahmad G, O\u2019Connor EE, Muschelli J, Laymon CM, Yang Z, Cohen AD, Aizenstein HJ, Klunk WE, Christian BT, Hwang SJ, Crainiceanu CM, Tudorascu DL (2021) A multi-scanner neuroimaging data harmonization using RAVEL and ComBat. Neuroimage 245:118703","journal-title":"Neuroimage"},{"key":"12811_CR31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00429-019-02017-1","volume":"225","author":"M Febo","year":"2020","unstructured":"Febo M, Perez PD, Ceballos-Diaz C, Colon-Perez LM, Zeng H, Ofori E, Golde TE, Vaillancourt DE, Chakrabarty P (2020) Diffusion magnetic resonance imaging-derived free water detects neurodegenerative pattern induced by interferon-\u03b3. Brain Struct Funct 225:427\u2013439","journal-title":"Brain Struct Funct"},{"key":"12811_CR32","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1093\/brain\/awr307","volume":"134","author":"Y Wang","year":"2011","unstructured":"Wang Y, Wang Q, Haldar JP, Yeh FC, Xie M, Sun P, Tu TW, Trinkaus K, Klein RS, Cross AH, Song SK (2011) Quantification of increased cellularity during inflammatory demyelination. Brain 134:3590\u20133601","journal-title":"Brain"},{"key":"12811_CR33","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2023.120324","volume":"279","author":"T Pieciak","year":"2023","unstructured":"Pieciak T, Par\u00eds G, Beck D, Maximov II, Trist\u00e1n-Vega A, de Luis-Garc\u00eda R, Westlye LT, Aja-Fern\u00e1ndez S (2023) Spherical means-based free-water volume fraction from diffusion MRI increases non-linearly with age in the white matter of the healthy human brain. Neuroimage 279:120324","journal-title":"Neuroimage"},{"key":"12811_CR34","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.neurobiolaging.2014.10.029","volume":"36","author":"E Ofori","year":"2015","unstructured":"Ofori E, Pasternak O, Planetta PJ, Burciu R, Snyder A, Febo M, Golde TE, Okun MS, Vaillancourt DE (2015) Increased free water in the substantia nigra of Parkinson\u2019s disease: a single-site and multi-site study. Neurobiol Aging 36:1097\u20131104","journal-title":"Neurobiol Aging"},{"key":"12811_CR35","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/brain\/awab039","volume":"144","author":"L Zhou","year":"2021","unstructured":"Zhou L, Li G, Zhang Y, Zhang M, Chen Z, Zhang L, Wang X, Zhang M, Ye G, Li Y, Chen S, Li B, Wei H, Liu J (2021) Increased free water in the substantia nigra in idiopathic REM sleep behaviour disorder. Brain 144:1488\u20131497","journal-title":"Brain"},{"key":"12811_CR36","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/brain\/awx146","volume":"140","author":"RG Burciu","year":"2017","unstructured":"Burciu RG, Ofori E, Archer DB, Wu SS, Pasternak O, McFarland NR, Okun MS, Vaillancourt DE (2017) Progression marker of Parkinson\u2019s disease: a 4-year multi-site imaging study. Brain 140:2183\u20132192","journal-title":"Brain"},{"key":"12811_CR37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/brain\/awv361","volume":"139","author":"PJ Planetta","year":"2016","unstructured":"Planetta PJ, Ofori E, Pasternak O, Burciu RG, Shukla P, DeSimone JC, Okun MS, McFarland NR, Vaillancourt DE (2016) Free-water imaging in Parkinson\u2019s disease and atypical parkinsonism. Brain 139:495\u2013508","journal-title":"Brain"},{"key":"12811_CR38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(18)30032-2","volume":"17","author":"SY Liu","year":"2018","unstructured":"Liu SY, Wile DJ, Fu JF, Valerio J, Shahinfard E, McCormick S, Mabrouk R, Vafai N, McKenzie J, Neilson N, Perez-Soriano A, Arena JE, Cherkasova M, Chan P, Zhang J, Zabetian CP, Aasly JO, Wszolek ZK, McKeown MJ, Adam MJ, Ruth TJ, Schulzer M, Sossi V, Stoessl AJ (2018) The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson\u2019s disease: a cross-sectional PET study. Lancet Neurol 17:309\u2013316","journal-title":"Lancet Neurol"},{"key":"12811_CR39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuroscience.2014.09.049","volume":"302","author":"J Schapansky","year":"2015","unstructured":"Schapansky J, Nardozzi JD, LaVoie MJ (2015) The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson\u2019s disease. Neuroscience 302:74\u201388","journal-title":"Neuroscience"},{"key":"12811_CR40","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature01339","volume":"421","author":"H Wang","year":"2003","unstructured":"Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421:384\u2013388","journal-title":"Nature"},{"key":"12811_CR41","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/brain\/awh607","volume":"128","author":"JR Adams","year":"2005","unstructured":"Adams JR, van Netten H, Schulzer M, Mak E, McKenzie J, Strongosky A, Sossi V, Ruth TJ, Lee CS, Farrer M, Gasser T, Uitti RJ, Calne DB, Wszolek ZK, Stoessl AJ (2005) PET in LRRK2 mutations: comparison to sporadic Parkinson\u2019s disease and evidence for presymptomatic compensation. Brain 128:2777\u20132785","journal-title":"Brain"},{"key":"12811_CR42","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1212\/01.wnl.0000335973.66333.58","volume":"71","author":"R Nandhagopal","year":"2008","unstructured":"Nandhagopal R, Mak E, Schulzer M, McKenzie J, McCormick S, Sossi V, Ruth TJ, Strongosky A, Farrer MJ, Wszolek ZK, Stoessl AJ (2008) Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study. Neurology 71:1790\u20131795","journal-title":"Neurology"},{"key":"12811_CR43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/mds.26450","volume":"31","author":"DJ Wile","year":"2016","unstructured":"Wile DJ, Dinelle K, Vafai N, McKenzie J, Tsui JK, Schaffer P, Ding YS, Farrer M, Sossi V, Stoessl AJ (2016) A scan without evidence is not evidence of absence: scans without evidence of dopaminergic deficit in a symptomatic leucine-rich repeat kinase 2 mutation carrier. Mov Disord 31:405\u2013409","journal-title":"Mov Disord"},{"key":"12811_CR44","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/mds.23356","volume":"25","author":"V Sossi","year":"2010","unstructured":"Sossi V, de la Fuente-Fern\u00e1ndez R, Nandhagopal R, Schulzer M, McKenzie J, Ruth TJ, Aasly JO, Farrer MJ, Wszolek ZK, Stoessl JA (2010) Dopamine turnover increases in asymptomatic LRRK2 mutations carriers. Mov Disord 25:2717\u20132723","journal-title":"Mov Disord"},{"key":"12811_CR45","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1474-4422(17)30056-X","volume":"16","author":"DJ Wile","year":"2017","unstructured":"Wile DJ, Agarwal PA, Schulzer M, Mak E, Dinelle K, Shahinfard E, Vafai N, Hasegawa K, Zhang J, McKenzie J, Neilson N, Strongosky A, Uitti RJ, Guttman M, Zabetian CP, Ding YS, Adam M, Aasly J, Wszolek ZK, Farrer M, Sossi V, Stoessl AJ (2017) Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies. Lancet Neurol 16:351\u2013359","journal-title":"Lancet Neurol"},{"key":"12811_CR46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-015-1392-5","volume":"129","author":"AK Liu","year":"2015","unstructured":"Liu AK, Chang RC, Pearce RK, Gentleman SM (2015) Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer\u2019s and Parkinson\u2019s disease. Acta Neuropathol 129:527\u2013540","journal-title":"Acta Neuropathol"},{"key":"12811_CR47","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/brain\/awac127","volume":"146","author":"NJ Ray","year":"2023","unstructured":"Ray NJ, Lawson RA, Martin SL, Sigurdsson HP, Wilson J, Galna B, Lord S, Alcock L, Duncan GW, Khoo TK, O\u2019Brien JT, Burn DJ, Taylor JP, Rea RC, Bergamino M, Rochester L, Yarnall AJ (2023) Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson\u2019s disease. Brain 146:1053\u20131064","journal-title":"Brain"},{"key":"12811_CR48","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fnagi.2014.00248","volume":"6","author":"JO Aasly","year":"2014","unstructured":"Aasly JO, Johansen KK, Br\u00f8nstad G, War\u00f8 BJ, Majbour NK, Varghese S, Alzahmi F, Paleologou KE, Amer DA, Al-Hayani A, El-Agnaf OM (2014) Elevated levels of cerebrospinal fluid \u03b1-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers. Front Aging Neurosci 6:248","journal-title":"Front Aging Neurosci"},{"key":"12811_CR49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2018.08.018","volume":"120","author":"S Novello","year":"2018","unstructured":"Novello S, Arcuri L, Dovero S, Dutheil N, Shimshek DR, Bezard E, Morari M (2018) G2019S LRRK2 mutation facilitates \u03b1-synuclein neuropathology in aged mice. Neurobiol Dis 120:21\u201333","journal-title":"Neurobiol Dis"},{"key":"12811_CR50","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00401-019-01995-0","volume":"137","author":"G Bieri","year":"2019","unstructured":"Bieri G, Brahic M, Bousset L, Couthouis J, Kramer NJ, Ma R, Nakayama L, Monbureau M, Defensor E, Sch\u00fcle B, Shamloo M, Melki R, Gitler AD (2019) LRRK2 modifies \u03b1-syn pathology and spread in mouse models and human neurons. Acta Neuropathol 137:961\u2013980","journal-title":"Acta Neuropathol"},{"key":"12811_CR51","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(16)00060-0","volume":"15","author":"D Salat","year":"2016","unstructured":"Salat D, Noyce AJ, Schrag A, Tolosa E (2016) Challenges of modifying disease progression in prediagnostic Parkinson\u2019s disease. Lancet Neurol 15:637\u2013648","journal-title":"Lancet Neurol"},{"key":"12811_CR52","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/WCO.0000000000000584","volume":"31","author":"V Rispoli","year":"2018","unstructured":"Rispoli V, Schreglmann SR, Bhatia KP (2018) Neuroimaging advances in Parkinson\u2019s disease. Curr Opin Neurol 31:415\u2013424","journal-title":"Curr Opin Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12811-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12811-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12811-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T17:53:17Z","timestamp":1738173197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12811-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["12811"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12811-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"assertion":[{"value":"7 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors confirm that all methods were carried out in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The scientific guarantor of this publication is Dr. Chao Wang. The authors confirm that all methods were carried out in accordance with relevant guidelines and regulations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}}],"article-number":"33"}}